Why Inovio Stock Is Sinking Again Today

12:07pm, Wednesday, 12'th Aug 2020
Questions about its coronavirus vaccine candidate continue to weigh on the biotech stock.
Inovio did not get the government funding or pre-orders like its competitors did, so if it happens later, INO stock will respond positively The post Inovio Still Has a Chance to Break Out in a Big Way
Inovio Pharmaceuticals Inc (NASDAQ: INO) failed to inspire confidence among investors despite revealing in its second-quarter earnings report that it is on track for a September start for a Phase 2/3
On Wall Street, it seemed as though Tuesday would be a repeat of Monday, with strength in the Dow Jones Industrial Average (DJINDICES: ^DJI) coupled with weakness in the tech-heavy Nasdaq Composite.

Coronavirus Latest: Tuesday, August 11

07:17pm, Tuesday, 11'th Aug 2020
Both Inovio and BionNTech announced that they are making headway in their coronavirus vaccine trials, and will be able to meet deadlines toward the end of the year or a the start of 2021. Yahoo Financ
Inovio Pharmaceuticals Inc. shares tumbled 22% Tuesday, a day after the company reported a wider-than-expected second-quarter loss and offered a limited...
Inovio Pharmaceuticals Inc (NASDAQ: INO) failed to inspire confidence among investors despite revealing in its second-quarter earnings report that it is on track for a September start for a Phase 2/3
What looked like another rotation day turned into something more negative.
These are the stocks posting the largest moves in midday trading.
Russia's surprise vaccine announcement isn't sitting well with shareholders of Dynavax, Heat Biologics, or Inovio Pharmaceuticals.
Stifel cut its target after the company reported a much wider second quarter loss than analysts expected.
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) * Allovir Inc (NASDAQ: ALVR) * BioLife Solutions Inc (NASDAQ: BLFS) * BioSpecifics Technologies Corp. (NASDAQ: BSTC) (reacted to sec
Stifel analysts cut their stock price target for Inovio Pharmaceuticals Inc. undefined to $16 from $24 on Tuesday, after the company posted a...
Stifel analysts cut their stock price target for Inovio Pharmaceuticals Inc. to $16 from $24 on Tuesday, after the company posted a wider-than-expected second-quarter loss and revenue that fell short
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE